Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 10 Show results per page	View Search Criteria \| Help With Results

Last Modified: 9/18/2008 First Published: 6/23/2003


1.		Phase III Randomized Study of Interstitial Brachytherapy With or Without External Beam Radiotherapy in Patients With Intermediate-Risk Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI				RTOG-0232 RTOG-0232, CTSU, NCT00063882

Last Modified: 9/18/2008 First Published: 2/20/2004


2.		Phase III Study of Neoadjuvant Chemoreduction Comprising Carboplatin and Vincristine and Standardized Local Ophthalmic Therapy in Patients With Group B Intraocular Retinoblastoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				5 and under				NCI				COG-ARET0331 ARET0331, NCT00079417

Last Modified: 9/19/2008 First Published: 3/24/2005


3.		Phase III Randomized Study of Sublobar Resection With Versus Without Intraoperative Brachytherapy in High-Risk Patients With Stage I Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI				ACOSOG-Z4032 ACOSOG-Z4032, NCT00107172


4.		I-125 Versus Pd-103 for Medium Risk Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				40 to 90				Other				02-4407-V04 NCT00486499

Last Modified: 9/15/2008 First Published: 4/21/2008


5.		Phase III Randomized Study of Neoadjuvant Luteinizing Hormone-Releasing Hormone (LHRH) Agonist Therapy and Permanent Iodine I 125 Implantation With Versus Without Adjuvant LHRH Agonist Therapy in Patients With Previously Untreated Intermediate-Risk Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				20 to 75				Other				JUSMH-BRI-GU05-01 BRI_GU05-01, NCT00664456


6.		Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Supportive care, Treatment				Active				50 and over				Other				IRB 8488 CASE16804, NCT00252941

Last Modified: 9/6/2008 First Published: 3/16/2007


7.		Phase II Study of Transperineal Ultrasound-Guided Iodine I 125 or Palladium Pd 103 Brachytherapy in Patients With Locally Recurrent Adenocarcinoma of the Prostate Previously Treated With External-Beam Radiotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI				RTOG-0526 RTOG-0526, NCT00450411


8.		High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy Implantation

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Diagnostic, Treatment				Active				18 and over				Other				NA-15-0003 NCT00126854

First Published: 9/18/2007


9.		Study of Brachytherapy With Iodine I-125 in Patients With Localized Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Treatment				Active				Any age				Other				TUSM-BRI-GU-04-01 BRI GU 04-01, NCT00534196


10.		Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Diagnostic				Active				Over 18				Other				CCR3047 NCT00749697

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute